Skip to content

Public FDA record

Z-1441-06: Staclot LA 20 tests, Catalog #0594, LA Assay, Hexagonal Phase Phospholipid Neutralization Assay.

Recall record Z-1441-06 for Diagnostica Stago, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1441-06
Company in FDA record
Diagnostica Stago, Inc.
FDA classification date
Aug 26, 2006
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Decrease in sensitivity ; This could result in a false negative result for patients with weak to moderate lupus anticoagulants.

Source facts

Action
Recall notification letters were sent out via first class mail on July 18, 2006.
Initiated
2006-07-18
Root cause
Other
Terminated
2006-11-06
Distribution
Nationwide
Recall number
Z-1441-06
Recall status
Terminated
CDRH record ID
47247
FDA classified
2006-08-26
Recall event number
35946

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗